The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Effects of recombinant human growth hormone on metabolic indices, body composition, and bone turnover in healthy elderly women
Abstract
We conducted a controlled trial of recombinant human GH (rhGH) in 27 healthy elderly women (66.7 +/- 3.0 yr), of whom 8 took a stable dose of replacement estrogen throughout the study (plus estrogen group). Hormone or placebo was given as a single daily injection. A total of 19 women were assigned to receive rhGH at an initial daily dose of 0.043 mg/kg BW. After several weeks, 50% dose reductions were necessitated by side-effects. The last 7 subjects to be enrolled began treatment at this reduced level. A total of 13 women assigned to rhGH and 14 women assigned to placebo completed 6 months of drug treatment. In the rhGH group, 6 women took estrogen; thus, the effects of rhGH were assessed separately by estrogen status. Circulating insulin-like growth factor-I (IGF-I) levels were similar at baseline (rhGH, 133 +/- 40.4 micrograms/L; placebo, 128 +/- 13). rhGH increased IGF-I and IGF-I-binding protein-3 (IGFBP-3) in all subjects [6 month IGF-I in plus estrogen women, 230 +/- 25.4 micrograms/L; in those not receiving estrogen (minus estrogen), 308 +/- 21.3]. No changes in IGF-I or IGFBP-3 occurred with placebo (IGF-I, 144 +/- 21.3 micrograms/L). Skinfold thickness measurements showed an 11% decrease in fat mass (P < 0.005) and a 9% decrease in percent fat after 6 months of rhGH treatment. No significant difference in nitrogen balance was seen in either group at 6 months, but rhGH increased creatinine clearance by 9.2% (P < 0.05). rhGH dramatically increased markers of bone turnover, with more pronounced effects in minus estrogen women. Hydroxyproline excretion increased by 20% and 80%, and pyridinoline excretion increased by 44% and 75% in plus and minus estrogen subgroups, respectively. Osteocalcin concentrations increased by more than 60% in minus estrogen women (P < 0.05), but did not change in the plus estrogen group. No changes were observed in circulating type I procollagen extension peptide in either group, and no change in any turnover marker was seen in the placebo group. rhGH did not alter blood pressure or circulating L-T4 levels, but a transient increase in serum T3 was observed in the minus estrogen group at 3 months. rhGH decreased low density lipoprotein cholesterol in the minus estrogen group, but otherwise no significant changes in circulating lipoproteins or fibrinogen were observed. Eight women assigned to rhGH and 14 placebo-treated women remained on blinded treatment through 12 months.(ABSTRACT TRUNCATED AT 400 WORDS)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Durnin, J. V. G. A., & Womersley, J. (1974) · British Journal of Nutrition · doi:10.1079/bjn19740060 · Cited by 6,343
New methods for calculating metabolic rate with special reference to protein metabolism
Weir, J. B. D. V. (1949) · The Journal of Physiology · doi:10.1113/jphysiol.1949.sp004363 · Cited by 5,603
Effects of Human Growth Hormone in Men over 60 Years Old
Rudman, D., Feller, A. G., Nagraj, H. S., Gergans, G. A., Lalitha, P. Y., Goldberg, A. F., Schlenker, R. A., Cohn, L., Rudman, I. W., & Mattson, D. E. (1990) · New England Journal of Medicine · doi:10.1056/nejm199007053230101 · Cited by 1,555
Age and bone mass as predictors of fracture in a prospective study.
Hui, S. L., Slemenda, C. W., & Johnston, C. C. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113523 · Cited by 1,166
Cummings, S. R. (1990) · JAMA · doi:10.1001/jama.263.5.665 · Cited by 1,011
Intermittent Cyclical Etidronate Treatment of Postmenopausal Osteoporosis
Watts, N. B., Harris, S. T., Genant, H. K., Wasnich, R. D., Miller, P. D., Jackson, R. D., Licata, A. A., Ross, P., Woodson, G. C., Yanover, M. J., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199007123230201 · Cited by 949
HO, K. Y., EVANS, W. S., BLIZZARD, R. M., VELDHUIS, J. D., MERRIAM, G. R., SAMOJLIK, E., FURLANETTO, R., ROGOL, A. D., KAISER, D. L., & THORNER, M. O. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-64-1-51 · Cited by 921
Prevention of spinal osteoporosis in oophorectomised women
Lindsay, R., Hart, D. M., Forrest, C., & Baird, C. (1980) · The Lancet · doi:10.1016/s0140-6736(80)92592-1 · Cited by 706
Impaired growth hormone secretion in the adult population: relation to age and adiposity.
Rudman, D., Kutner, M. H., Rogers, C. M., Lubin, M. F., Fleming, G. A., & Bain, R. P. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110164 · Cited by 641
The Relationship of Knee and Ankle Weakness to Falls in Nursing Home Residents: An Isokinetic Study
Whipple, R. H., Wolfson, L. I., & Amerman, P. M. (1987) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1987.tb01313.x · Cited by 634
Evaluation and regulation of body build and composition
Behnke, A. R., & Wilmore, J. H. (1974) · Prentice Hall eBooks · Cited by 627
MAZESS, R. B. (1982) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-198205000-00037 · Cited by 550
A simplified method for determination of residual lung volumes.
Wilmore, J. H. (1969) · Journal of Applied Physiology · doi:10.1152/jappl.1969.27.1.96 · Cited by 533
WEISSBERGER, A. J., HO, K. K. Y., & LAZARUS, L. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-72-2-374 · Cited by 514
A Prospective Study of Lipoprotein(a) and the Risk of Myocardial Infarction
Ridker, P. M. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03510180065035 · Cited by 512
Larsson, L., Sjödin, B., & Karlsson, J. (1978) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1978.tb06187.x · Cited by 495
Growth Hormone, Body Composition, and Aging
Rudman, D. (1985) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1985.tb04195.x · Cited by 361
Jauhiainen, M., Koskinen, P., Ehnholm, C., Frick, M. H., Mänttäri, M., Manninen, V., & Huttunen, J. K. (1991) · Atherosclerosis · doi:10.1016/0021-9150(91)90007-p · Cited by 354
Growth hormone treatment in growth hormone-deficient adults. I. Effects on muscle mass and strength
Cuneo, R. C., Salomon, F., Wiles, C. M., Hesp, R., & Sonksen, P. H. (1991) · Journal of Applied Physiology · doi:10.1152/jappl.1991.70.2.688 · Cited by 334
Lipoprotein(a). A unique risk factor for atherothrombotic disease.
Loscalzo, J. (1990) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.10.5.672 · Cited by 296
Effects of Short Term Administration of Recombinant Human Growth Hormone to Elderly People*
MARCUS, R., BUTTERFIELD, G., HOLLOWAY, L., GILLILAND, L., BAYLINK, D. J., HINTZ, R. L., & SHERMAN, B. M. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-70-2-519 · Cited by 282
Self-citationA critical review of bone mass and the risk of fractures in osteoporosis
Ross, P. D., Davis, J. W., Vogel, J. M., & Wasnich, R. D. (1990) · Calcified Tissue International · doi:10.1007/bf02555036 · Cited by 275
Nitrogen Balance as Related to Caloric and Protein Intake in Active Young Men
CALLOWAY, D. H., & SPECTOR, H. (1954) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/2.6.405 · Cited by 269
Ernst, M., & Froesch, E. R. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(88)90570-0 · Cited by 252
DAWSON-HUGHES, B., STERN, D., GOLDMAN, J., & REICHLIN, S. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-63-2-424 · Cited by 249
Lipoprotein(a). A genetic risk factor for premature coronary heart disease
Scanu, A. M. (1992) · JAMA · doi:10.1001/jama.267.24.3326 · Cited by 225
Isometric and dynamic endurance as a function of age and skeletal muscle characteristics
Larsson, L., & Karlsson, J. (1978) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1978.tb06259.x · Cited by 209
Anthropometric Indicators and Hip Fracture: The NHANES I Epidemiologic Follow‐up Study
Farmer, M. E., Harris, T., Madans, J. H., Wallace, R. B., Cornoni‐Huntley, J., & White, L. R. (1989) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1989.tb01562.x · Cited by 196
Intermittent Cyclical Etidronate Treatment of Postmenopausal Osteoporosis
WATTS, N. B., HARRIS, S. T., GENANT, H. K., WASNICH, E. D., MILLER, P. D., JACKSON, R. D., LICATA, A. A., ROSS, P., WOODSON, G. G., YANOVER, M. J., et al. (1991) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-199101000-00023 · Cited by 190
Effects of Human Growth Hormone on Body Composition in Elderly Men
Rudman, D., Feller, A. G., Cohn, L., Shetty, K. R., Rudman, I. W., & Draper, M. W. (1991) · Hormone Research · doi:10.1159/000182193 · Cited by 182
Stracke, H., Schulz, A., Moeller, D., Rossol, S., & Schatz, H. (1984) · Acta Endocrinologica · doi:10.1530/acta.0.1070016 · Cited by 176
The adult decline in lean body mass.
Forbes, G. B., & Halloran, E. (1976) · PubMed · Cited by 170
GLASS, P., ROSENFELD, R. G., BAKER, B. K., LIU, F., & HINTZ, R. L. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-63-5-1186 · Cited by 167
Conjugated Estrogens in the Treatment of Postmenopausal Women with Hyperparathyroidism
MARCUS, R., MADVIG, P., CRIM, M., PONT, A., & KOSEK, J. (1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-100-5-633 · Cited by 166
Dr. Brixen, K., Nielsen, H. K., Mosekilde, L., & Flyvbjerg, A. (1990) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650050610 · Cited by 166
Cheema, C., Grant, B., & Marcus, R. (1989) · Journal of Clinical Investigation · doi:10.1172/jci113915 · Cited by 156
Chenu, C., Valentin-Opran, A., Chavassieux, P., Saez, S., Meunier, P. J., & Delmas, P. D. (1990) · Bone · doi:10.1016/8756-3282(90)90054-3 · Cited by 142
Growth Hormone (GH) Receptors in Clonal Osteoblast Like Cells Mediate a Mitogenic Response to GH*
Barnard, R. T., Ng, K. W., Martin, T. J., & Waters, M. J. (1991) · Endocrinology · doi:10.1210/endo-128-3-1459 · Cited by 141
Effects of Growth Hormone in Osteoporosis
Aloia, J. F., ZANZI, I., Ellis, K. J., Jowsey, J., Roginsky, M. S., Wallach, S., & Cohn, S. H. (1976) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-43-5-992 · Cited by 108
Treatment of osteoporosis with calcitonin, with and without growth hormone
Aloia, J. F., Vaswani, A. N., Kapoor, A., Yeh, J. K., & Cohn, S. H. (1985) · Metabolism · doi:10.1016/0026-0495(85)90120-9 · Cited by 107
Lieberman, S. A., Mitchell, A., Marcus, R., Hintz, R. L., & Hoffman, A. R. (1994) · Hormone and Metabolic Research · doi:10.1055/s-2007-1001671 · Cited by 105
Age, Isometric Strength, Rate of Tension Development and Fiber Type Composition
Clarkson, P. M., Kroll, W., & Melchionda, A. M. (1981) · Journal of Gerontology · doi:10.1093/geronj/36.6.648 · Cited by 85
Effect of Growth Hormone on Skeletal Mass in Adult Dogs
Harris, W. H., & Heaney, R. P. (1969) · Nature · doi:10.1038/223403a0 · Cited by 77
NORMAL AND ABNORMAL BONE REMODELING IN MAN
Marcus, R. (1987) · Annual Review of Medicine · doi:10.1146/annurev.me.38.020187.001021 · Cited by 65
Growth hormone and adult bone remodelling
PARFITT, A. M. (1991) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1991.tb00929.x · Cited by 58
Franchimont, P., Urbain-Choffray, D., Lambelin, P., Fontaine, M.-A., Frangin, G., & Reginster, J. (1989) · European Journal of Endocrinology · doi:10.1530/acta.0.1200121 · Cited by 50
Packer, E., Holloway, L., Newhall, K. M., Kanwar, G., Butterfield, G. E., & Marcus, R. (1990) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650050812 · Cited by 36
Self-citation
Cited by
Giustina, A., & Veldhuis, J. D. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.6.0353 · Cited by 1,253
Ohlsson, C., Bengtsson, B.-A., Isaksson, O. G. P., Andreassen, T. T., & Slootweg, M. C. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.1.0324 · Cited by 855
Endocrine Control of Body Composition in Infancy, Childhood, and Puberty
Veldhuis, J. D., Roemmich, J. N., Richmond, E. J., Rogol, A. D., Lovejoy, J. C., Sheffield-Moore, M., Mauras, N., & Bowers, C. Y. (2005) · Endocrine Reviews · doi:10.1210/er.2003-0038 · Cited by 452
Morales, A. J., Haubrich, R. H., Hwang, J. Y., Asakura, H., & Yen, S. S. C. (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.00507.x · Cited by 418
Systematic review: the safety and efficacy of growth hormone in the healthy elderly
Liu, H., Bravata, D. M., Olkin, I., Nayak, S., Roberts, B., Garber, A. M., & Hoffman, A. R. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-2-200701160-00005 · Cited by 370
Metadata
- Authors
- Holloway, L.
- Venue
- Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1994-08-01
- Volume
- 79
- Issue
- 2
- Pages
- 470-479
- ISSN
- 0021-972X (ISSN-L)
- OpenAlex
- W2165675667
- Cited by
- 256
- References
- 47
- FWCI
- 15.89
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.